StockData
Harrow, Inc. logo

Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$32.16+2.64 (+8.94%)

Close on Nov 18, 2026Market cap $1.21BP/E –Yield –

Harrow revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Harrow's revenue for the twelve months ending Jun 30, 2026 was $275.59M, up 21.1% year over year. For fiscal 2025 it was $272.30M, up 36.4% from the year before. Over ten years it grew 39.6% a year on average. The highest annual figure on record is $272.30M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$272.30M+36.4%
FY2024Dec 31, 2024$199.61M+53.3%
FY2023Dec 31, 2023$130.19M+47.0%
FY2022Dec 31, 2022$88.60M+22.2%
FY2021Dec 31, 2021$72.48M+48.3%
FY2020Dec 31, 2020$48.87M-4.5%
FY2019Dec 31, 2019$51.17M+23.7%
FY2018Dec 31, 2018$41.37M+54.5%
FY2017Dec 31, 2017$26.77M+34.3%
FY2016Dec 31, 2016$19.94M+105.2%
FY2015Dec 31, 2015$9.72M+485.3%
FY2014Dec 31, 2014$1.66M+16500.0%
FY2013Dec 31, 2013$10.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$70.66M+10.9%
Q1 FY2026Mar 31, 2026$44.20M-7.6%
Q4 FY2025Dec 31, 2025$89.09M+33.3%
Q3 FY2025Sep 30, 2025$71.64M+45.4%
Q2 FY2025Jun 30, 2025$63.74M+30.2%
Q1 FY2025Mar 31, 2025$47.83M+38.3%
Q4 FY2024Dec 31, 2024$66.83M+83.8%
Q3 FY2024Sep 30, 2024$49.26M+43.8%
Q2 FY2024Jun 30, 2024$48.94M+46.2%
Q1 FY2024Mar 31, 2024$34.59M+32.5%
Q4 FY2023Dec 31, 2023$36.36M+78.8%
Q3 FY2023Sep 30, 2023$34.27M+50.1%
Q2 FY2023Jun 30, 2023$33.47M+43.5%
Q1 FY2023Mar 31, 2023$26.10M+18.0%
Q4 FY2022Dec 31, 2022$20.33M+0.7%
Q3 FY2022Sep 30, 2022$22.82M+22.0%
Q2 FY2022Jun 30, 2022$23.32M+28.6%
Q1 FY2022Mar 31, 2022$22.12M+43.2%
Q4 FY2021Dec 31, 2021$20.19M+38.3%
Q3 FY2021Sep 30, 2021$18.71M+29.9%
Q2 FY2021Jun 30, 2021$18.13M+125.0%
Q1 FY2021Mar 31, 2021$15.44M+30.7%
Q4 FY2020Dec 31, 2020$14.60M+15.8%
Q3 FY2020Sep 30, 2020$14.40M+12.9%
Q2 FY2020Jun 30, 2020$8.06M-40.4%
Q1 FY2020Mar 31, 2020$11.82M-3.8%
Q4 FY2019Dec 31, 2019$12.60M+10.7%
Q3 FY2019Sep 30, 2019$12.76M+18.8%
Q2 FY2019Jun 30, 2019$13.52M+30.2%
Q1 FY2019Mar 31, 2019$12.29M+38.6%
Q4 FY2018Dec 31, 2018$11.38M+55.2%
Q3 FY2018Sep 30, 2018$10.74M+65.6%
Q2 FY2018Jun 30, 2018$10.38M+51.4%
Q1 FY2018Mar 31, 2018$8.87M+45.4%
Q4 FY2017Dec 31, 2017$7.34M+26.7%
Q3 FY2017Sep 30, 2017$6.48M+33.4%
Q2 FY2017Jun 30, 2017$6.86M–
Q1 FY2017Mar 31, 2017$6.10M–
Q4 FY2016Dec 31, 2016$5.79M–
Q3 FY2016Sep 30, 2016$4.86M–

More Harrow figures

See a number that looks wrong?